ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10BB12 | G | Glimepiride - 3mg | 4730 | 148222/03 | DIAMERIL | 3mg | 30 | Tablet | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 308,880 L.L | 23.08 | A1 | 06/11/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10BB12 | B | Glimepiride - 3mg | 10881 | 27822/1 | AMARYL | 3mg | 30 | Tablet | Oral | Mersaco | Sanofi SpA | Italy | 394,594 L.L | 23.08 | A1 | Sanofi Aventis Deutschland GmbH | Germany | 06/11/20 | 0 |
A10BB12 | G | Glimepiride - 3mg | 6708 | 219297/09 | AMEPRIDE | 3mg | 30 | Tablet | Oral | Premium Serve Drugstore Co. P.S.D. SAL | The United Pharmaceutical Manufacturing Co Ltd | Jordan | 216,216 L.L | 23.08 | A1 | The United Pharmaceutical Manufacturing Co Ltd | Jordan | 06/11/20 | 0 |
A10BB12 | G | Glimepiride - 3mg | 6839 | 168003/10 | GLIM | 3mg | 30 | Tablet | Oral | Khalil Fattal & Fils S.A.L. | Spimaco | Saudi Arabia | 536,486 L.L | 23.08 | A1 | Spimaco | Saudi Arabia | 06/11/20 | 0 |
A10BB12 | G | Glimepiride - 3mg | 6704 | 219307/09 | GLYPRIDE | 3mg | 30 | Tablet | Oral | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 574,324 L.L | 23.08 | A1 | Julphar | United Arab Emirates | 06/11/20 | 0 |
A10BB12 | G | Glimepiride - 3mg | 5929 | 221855/08 | JOSWE GLEMAX 3 | 3mg | 30 | Caplet | Oral | The Lebanese Pharmacists SAL | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 509,459 L.L | 23.08 | A1 | 06/11/20 | 0 | ||
A10BB12 | G | Glimepiride - 3mg | 5124 | 24522/07 | ORBIDE | 3mg | 30 | Tablet | Oral | Medi drug International SAL (MDI) | Pharmadex licensed by Orbucell pharma Canada | Lebanon | 769,626 L.L | 23.08 | A2 | 06/11/20 | 0 |